FDA pushing drugmakers to lower Ambien dosages
January 10, 2013 (WLS) -- The Food and Drug Administration is warning consumers about the effects of insomnia drug Ambien and recommending that the bedtime dose be lowered.
There's new data that shows levels of the drug called Zolpidem (Zolpidem is sold under several names including Ambien) may be high enough to impair alertness in some patients the morning after using it.
The manufacturer is being asked to lower the recommended doses.
Women appear to be more susceptible to the risk as they eliminate Zolpidem from their bodies slower than men do.
Zolpidem is also marketed under several names: Ambien, Ambien CR, Edluar and Zolpimist.
In the meantime patients should speak to their doctors.
- Indiana Toll Road reopened after tanker truck rollover 2 min ago
- Carbon monoxide injures 12 in Skokie
- Video: I-Team Mall Security
- ABC7 Weather Forecast
- London theater balcony believed to have collapsed 13 min ago
- Target credit card breach affects 40 million accounts 31 min ago
- Larry Lujack dies at 73, wife says body to be donated
- 3 dead in 3 South Side shootings in 3 hours
- Deal requires removal of Chicago 'petcoke' piles
- Rogers Park stabbing seriously injures woman, 21
- City triples budget to board up closed CPS schools
- Teen dies day after Little Village shooting
- abcnews: 'Duck Dynasty' Puts Star on Hiatus